Research productivity and collaboration of the NIH-funded HIV vaccine trials network: A bibliometric analysis

被引:6
|
作者
Nye, Jonathan [1 ]
D'Souza, M. Patricia [1 ,2 ]
Hu, Dale [1 ,2 ]
Ghosh, Dolan [1 ]
机构
[1] NIAID, MSC 9808,Bldg 5601,5601 Fishers Lane, Rockville, MD 20852 USA
[2] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
Bibliometrics; Outcomes; HIV vaccine; HIV; HIV/AIDS RESEARCH; AIDS; EQUITY;
D O I
10.1016/j.heliyon.2021.e06005
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The HIV Vaccine Trials Network (HVTN) is the world's largest publicly funded, multi-disciplinary international collaboration facilitating the development of vaccines to prevent HIV/AIDS and has conducted the vast majority of HIV/AIDS clinical trials since its inception in 1999. Although scientific findings from the program have been published in scholarly journals, the impact of a large scientific research network such as the HVTN on the HIV/AIDS vaccine field has not been assessed. This paper describes and elucidates the productivity, influence, and collaboration among HVTN researchers over the last two decades. Our analyses indicate that the HVTN has funded a large number of HIV/AIDS vaccine safety and efficacy clinical trials through a strong global network of clinical sites. In addition, several metrics indicate HVTN researchers also published original research articles that are influential in the HIV vaccine field. Scientific research collaboration is critically important in a complex and multidisciplinary field such as HIV vaccine development as it allows improved sharing of knowledge and expertise as well as the pooling of resources and data. We found that collaboration in the HIV vaccine field increased during this time period and collaboration among HVTN authors increased even more. Combining these productivity, influence, and collaboration metrics with research outcomes can provide a comprehensive assessment of large complex programs such as the HVTN.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research
    Siskind, Rona L.
    Andrasik, Michele
    Karuna, Shelly T.
    Broder, Gail B.
    Collins, Clare
    Liu, Albert
    Lucas, Jonathan Paul
    Harper, Gary W.
    Renzullo, Philip O.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 72 : S243 - S247
  • [2] NIH-Funded Research, Clinical Trials and Program Projects
    Deye, J.
    Fraass, B.
    Bortfeld, T.
    Michalski, J.
    [J]. MEDICAL PHYSICS, 2015, 42 (06) : 3690 - 3691
  • [3] Access to NIH-funded research
    Hampton, T
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (12): : 1440 - 1440
  • [5] Public access to NIH-funded research
    Steinbrook, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17): : 1739 - 1741
  • [6] Survey of Community Engagement in NIH-Funded Research
    Hood, Nancy E.
    Brewer, Tracy
    Jackson, Rebecca
    Wewers, Mary Ellen
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2010, 3 (01): : 19 - 22
  • [7] Healing the NIH-Funded Biomedical Research Enterprise
    Germain, Ronald N.
    [J]. CELL, 2015, 161 (07) : 1485 - 1491
  • [8] A bibliometric analysis of the top 50 NIH-Funded colleges of pharmacy using two databases
    Burghardt, Kyle J.
    Howlett, Bradley H.
    Fern, Stephanie M.
    Burghardt, Paul R.
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (07): : 941 - 948
  • [9] THE RISING COST OF NIH-FUNDED BIOMEDICAL-RESEARCH
    KENNEDY, TJ
    [J]. ACADEMIC MEDICINE, 1990, 65 (02) : 63 - 73
  • [10] Profile of the Portfolio of NIH-Funded HIV Implementation Research Projects to Inform Ending the HIV Epidemic Strategies
    Queiroz, Artur
    Mongrella, Melissa
    Keiser, Brennan
    Li, Dennis H.
    Benbow, Nanette
    Mustanski, Brian
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 90 : S23 - S31